MEI Pharma, Inc. (MEIP) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
MEI Pharma, Inc. (MEIP) Bundle
Enhance your investment strategies with the MEI Pharma, Inc. (MEIP) DCF Calculator! Get access to authentic financial data, adjust growth projections and expenses, and instantly visualize how these changes affect the intrinsic value of MEI Pharma, Inc. (MEIP).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28.9 | 25.5 | 40.7 | 48.8 | 65.3 | 81.9 | 102.6 | 128.6 | 161.2 | 202.1 |
| Revenue Growth, % | 0 | -11.68 | 59.38 | 19.95 | 33.76 | 25.35 | 25.35 | 25.35 | 25.35 | 25.35 |
| EBITDA | -25.6 | -60.1 | -75.2 | -36.8 | 26.4 | -52.9 | -66.4 | -83.2 | -104.3 | -130.7 |
| EBITDA, % | -88.5 | -235.52 | -184.68 | -75.31 | 40.4 | -64.68 | -64.68 | -64.68 | -64.68 | -64.68 |
| Depreciation | .1 | .3 | 1.2 | 1.8 | .4 | 1.4 | 1.8 | 2.3 | 2.8 | 3.6 |
| Depreciation, % | 0.37699 | 1.12 | 3.03 | 3.72 | 0.58655 | 1.77 | 1.77 | 1.77 | 1.77 | 1.77 |
| EBIT | -25.7 | -60.4 | -76.4 | -38.6 | 26.0 | -53.7 | -67.3 | -84.4 | -105.8 | -132.6 |
| EBIT, % | -88.88 | -236.63 | -187.71 | -79.03 | 39.81 | -65.62 | -65.62 | -65.62 | -65.62 | -65.62 |
| Total Cash | 182.6 | 153.4 | 153.3 | 100.7 | 38.3 | 75.1 | 94.1 | 118.0 | 147.9 | 185.4 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.9 | 7.6 | 10.0 | .1 | .0 | 10.6 | 13.3 | 16.6 | 20.9 | 26.2 |
| Account Receivables, % | 10.17 | 29.69 | 24.68 | 0.17412 | 0 | 12.94 | 12.94 | 12.94 | 12.94 | 12.94 |
| Inventories | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Inventories, % | 0 | 0.000003916193 | 0.000002457184 | 0 | 0 | 0.000001274675 | 0.000001274675 | 0.000001274675 | 0.000001274675 | 0.000001274675 |
| Accounts Payable | 2.4 | 6.4 | 7.9 | 6.1 | 3.2 | 11.5 | 14.4 | 18.1 | 22.6 | 28.4 |
| Accounts Payable, % | 8.43 | 24.89 | 19.46 | 12.57 | 4.85 | 14.04 | 14.04 | 14.04 | 14.04 | 14.04 |
| Capital Expenditure | -.9 | -.7 | -.5 | .0 | .0 | -1.2 | -1.5 | -1.8 | -2.3 | -2.9 |
| Capital Expenditure, % | -3.09 | -2.77 | -1.18 | -0.0716978 | -0.01072025 | -1.42 | -1.42 | -1.42 | -1.42 | -1.42 |
| Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBITAT | -26.3 | -49.4 | -76.4 | -38.6 | 26.0 | -51.7 | -64.9 | -81.3 | -101.9 | -127.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -27.6 | -50.5 | -76.5 | -28.6 | 23.5 | -53.7 | -64.3 | -80.6 | -101.0 | -126.6 |
| WACC, % | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -331.4 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -129 | |||||||||
| Terminal Value | -2,233 | |||||||||
| Present Terminal Value | -1,535 | |||||||||
| Enterprise Value | -1,867 | |||||||||
| Net Debt | -4 | |||||||||
| Equity Value | -1,863 | |||||||||
| Diluted Shares Outstanding, MM | 7 | |||||||||
| Equity Value Per Share | -279.63 |
What You Will Get
- Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real MEIP financials.
- Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
- Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
- Automatic Calculations: Instantly observe the effect of your inputs on MEI Pharma’s valuation.
- Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
- User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.
Key Features
- Accurate MEI Pharma Financials: Access reliable pre-loaded historical data and future forecasts.
- Customizable Forecast Variables: Modify highlighted cells for WACC, growth rates, and profit margins.
- Real-Time Calculations: Automatic adjustments to DCF, Net Present Value (NPV), and cash flow assessments.
- Interactive Dashboard: User-friendly charts and summaries to illustrate your valuation findings.
- Designed for All Users: A straightforward, intuitive layout tailored for investors, CFOs, and consultants.
How It Works
- Download the Template: Gain immediate access to the Excel-based MEI Pharma, Inc. (MEIP) DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other variables.
- Instant Calculations: The model automatically recalculates MEI Pharma, Inc.'s (MEIP) intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial analysis decisions.
Why Choose MEI Pharma, Inc. (MEIP)?
- Innovative Solutions: Benefit from cutting-edge therapies that address unmet medical needs.
- Strong Research Focus: Our commitment to scientific excellence ensures high-quality drug development.
- Patient-Centric Approach: We prioritize the health and well-being of patients in all our initiatives.
- Experienced Team: Our professionals bring a wealth of knowledge and expertise to the pharmaceutical field.
- Proven Track Record: Trusted by investors and healthcare providers for delivering impactful results.
Who Should Use This Product?
- Professional Investors: Develop comprehensive and trustworthy valuation models for analyzing MEI Pharma, Inc. (MEIP) as part of their portfolio.
- Corporate Finance Teams: Evaluate valuation scenarios to inform strategic decisions within their organizations regarding MEI Pharma, Inc. (MEIP).
- Consultants and Advisors: Deliver precise valuation insights related to MEI Pharma, Inc. (MEIP) for their clients.
- Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling focused on MEI Pharma, Inc. (MEIP).
- Biotech Enthusiasts: Gain insights into how biotechnology companies like MEI Pharma, Inc. (MEIP) are valued in the market.
What the Template Contains
- Operating and Balance Sheet Data: Pre-filled MEI Pharma, Inc. (MEIP) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
- WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
- DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
- Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
- Key Ratios: Includes profitability, leverage, and efficiency ratios for MEI Pharma, Inc. (MEIP).
- Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.